WEST CHESTER, Pa., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics ...

Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Phathom Pharmaceuticals (PHAT – Research Report) on November 8 and set a price target of $28.00. The company’s shares closed ...

The company has invested heavily in China, the world's No. 2 pharmaceuticals market, and positioned operations there as core to its annual revenue targets through the end of this decade.

The Anglo-Swedish company, which has invested heavily in the world's No. 2 pharmaceuticals market, said last week that its China president, Leon Wang, was under investigation and that the ...

On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its market dominance by delaying competition for Copaxone, a leading multiple ...